Trial Design Solutions

  1. Assays To Drive Success In Anti-infective And Vaccine Development

    Learn how Q2 Solutions utilizes over 35 years of experience in infectious disease and immunology assay development and clinical diagnostic testing to provide you with solutions to meet your anti-infective and vaccine needs across the development continuum.

  2. Delivery Excellence For Anti-infective And Vaccine Development

    Learn more about how Q2 Solutions is providing best-in-class quality systems across a global vaccine network to ensure sample integrity for high-quality data delivery and better outcomes for your anti-infective or vaccine study.

  3. Q2 Comprehensive Sample Management Innovations

    Keep track of specimens collected, stored, shipped, tested and reported through innovative laboratory sample management .

  4. Q2 Laboratory Network Solutions

    Realize cost savings, faster contracting and simplified study data by centralizing your lab delivery and management with a proven lab services provider.

  5. DIA NOW

    DIA NOW enables on-demand, curated access to actionable insights across DIA's global platforms.

  6. Q2 Solutions CRO Partnership Model

    A comprehensive solution that streamlines the CRO plus clinical laboratory service model from start to finish.

  7. A Biomarker-Driven Approach To Developing Targeted Therapies

    Determine the steps to a successful biomarker strategy that will drive your precision medicines across the drug development continuum.

  8. Companion Diagnostic Expertise

    Learn more about how Q2 Solutions provides customers an optimal path to co-develop their companion diagnostic with clinical development of the therapeutic, regulatory submission and market launch.

  9. Global Anatomic Pathology Solutions

    Learn more about how Q2 Solutions uses innovative anatomic pathology solutions and adjunct molecular services to help drug developers optimize outcomes and ensure success in clinical trials, regulatory approvals and new product launches.

  10. Technical Innovations Advance Gene Expression Profiling

    Learn how Q2 recently modified the conventional SMART-Seq protocol, which led to an improved strategy for expression profiling via RNA sequencing from limiting amounts of RNA.